GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 149 filers reported holding GENMARK DIAGNOSTICS INC in Q4 2020. The put-call ratio across all filers is 2.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $3,650,000 | +123.7% | 250,000 | -16.7% | 0.01% | +100.0% |
Q1 2018 | $1,632,000 | -60.9% | 300,000 | -70.0% | 0.00% | -55.6% |
Q4 2017 | $4,169,000 | -58.8% | 999,857 | -4.8% | 0.01% | -64.0% |
Q3 2017 | $10,110,000 | -38.9% | 1,049,857 | -25.0% | 0.02% | -39.0% |
Q2 2017 | $16,560,000 | -37.0% | 1,399,857 | -31.7% | 0.04% | -37.9% |
Q1 2017 | $26,279,000 | -4.6% | 2,049,857 | -8.9% | 0.07% | -12.0% |
Q4 2016 | $27,538,000 | -10.2% | 2,249,857 | -13.5% | 0.08% | -10.7% |
Q3 2016 | $30,678,000 | +30.6% | 2,599,857 | -3.7% | 0.08% | +31.2% |
Q2 2016 | $23,489,000 | +73.1% | 2,699,857 | +4.8% | 0.06% | +73.0% |
Q1 2016 | $13,570,000 | -21.4% | 2,575,036 | +15.7% | 0.04% | -17.8% |
Q4 2015 | $17,266,000 | +15.5% | 2,225,036 | +17.1% | 0.04% | +7.1% |
Q3 2015 | $14,955,000 | -18.2% | 1,900,227 | -5.9% | 0.04% | -8.7% |
Q2 2015 | $18,293,000 | -22.5% | 2,019,157 | +11.0% | 0.05% | -20.7% |
Q1 2015 | $23,613,000 | -4.9% | 1,819,157 | -0.3% | 0.06% | -4.9% |
Q4 2014 | $24,842,000 | +67.8% | 1,825,227 | +10.6% | 0.06% | +64.9% |
Q3 2014 | $14,802,000 | -33.7% | 1,650,227 | 0.0% | 0.04% | -36.2% |
Q2 2014 | $22,328,000 | +42.7% | 1,650,227 | +4.9% | 0.06% | +34.9% |
Q1 2014 | $15,643,000 | -27.2% | 1,573,751 | -2.7% | 0.04% | -24.6% |
Q4 2013 | $21,489,000 | +37.0% | 1,616,947 | +25.1% | 0.06% | +26.7% |
Q3 2013 | $15,688,000 | +152.3% | 1,292,276 | +115.0% | 0.04% | +136.8% |
Q2 2013 | $6,219,000 | +19.0% | 601,028 | +48.6% | 0.02% | +11.8% |
Q1 2013 | $5,224,000 | – | 404,372 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|